Pharmacologic nomenclature assigns every drug three names at different levels of abstraction — a chemical name specifying molecular constitution and atomic arrangement, a nonproprietary generic name that is universal across manufacturers and jurisdictions, and a proprietary brand name legally restricted to a single manufacturer — with orthographic capitalization marking the proprietary status of the last. Medication regulation superimposes two independent risk-classification systems on this nomenclature: a controlled-substance schedule ordering agents by abuse and dependence potential, which determines the legal constraints on prescribing and refilling, and a pregnancy risk classification ordering agents by evidence of fetal harm. Within pharmacology, these frameworks establish that a drug's identity and its legal handling are separate axes: naming enables unambiguous communication across settings, while scheduling and risk categories translate pharmacologic properties into enforceable prescribing rules.
Pharmacologic nomenclature assigns every drug three names at different levels of abstraction — a chemical name specifying molecular constitution and atomic arrangement, a nonproprietary generic name …